| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/07/2004 | EP1404676A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 04/07/2004 | EP1404674A2 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors |
| 04/07/2004 | EP1404672A1 Tyrosine kinase inhibitors |
| 04/07/2004 | EP1404669A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 04/07/2004 | EP1404668A1 Variolin derivatives and their use as antitumor agents |
| 04/07/2004 | EP1404663A1 Eurotinone and derivatives thereof, method for the production and use of the same |
| 04/07/2004 | EP1404659A1 4-aryl quinols and analogs thereof as therapeutic agents |
| 04/07/2004 | EP1404654A2 Calcilytic compounds |
| 04/07/2004 | EP1404652A1 A novel alkaloid derivative and a pharmaceutical composition containing the same |
| 04/07/2004 | EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 04/07/2004 | EP1404377A2 Improved chelator conjugates |
| 04/07/2004 | EP1404374A1 Slc2as as modifiers of the p53 pathway and methods of use |
| 04/07/2004 | EP1404371A2 Peptide-based compounds for targeting intergin receptors |
| 04/07/2004 | EP1404368A2 Mutant forms of cholera holotoxin as an adjuvant |
| 04/07/2004 | EP1404367A2 Use of polyclonal anti-hiv goat serum as a therapeutic agent |
| 04/07/2004 | EP1404366A2 Combination therapy of gamma-interferon and b cell specific antibodies |
| 04/07/2004 | EP1404365A2 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 04/07/2004 | EP1404364A1 Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity |
| 04/07/2004 | EP1404359A2 Methods of treatment involving human mda-7 |
| 04/07/2004 | EP1404357A1 Gonadotropin releasing hormone antagonists in gel-forming concentrations |
| 04/07/2004 | EP1404356A2 Cd10-activated prodrug compounds |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP1404349A1 Fat-binding polymers |
| 04/07/2004 | EP1404344A2 Bone anabolic compounds and methods of use |
| 04/07/2004 | EP1404343A2 Therapeutic combinations for the treatment of hormone deficiencies |
| 04/07/2004 | EP1404337A2 QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 04/07/2004 | EP1404334A1 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 04/07/2004 | EP1404330A1 Substituted 8-arylquinoline pde4 inhibitors |
| 04/07/2004 | EP1404323A1 Use of methylnaltrexone to treat immune suppression |
| 04/07/2004 | EP1404322A2 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof |
| 04/07/2004 | EP1404321A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
| 04/07/2004 | EP1404319A1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 04/07/2004 | EP1404318A2 Compounds and methods for regulating cell differentiation |
| 04/07/2004 | EP1404314A1 Aerosol formulations of delta 8 tetrahydrocannabinol |
| 04/07/2004 | EP1404308A1 Treatment of disorders secondary to organic impairments |
| 04/07/2004 | EP1404302A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 04/07/2004 | EP1404295A2 Sustained release drug delivery devices with coated drug cores |
| 04/07/2004 | EP1404279A2 Mutant forms of cholera holotoxin as an adjuvant |
| 04/07/2004 | EP1303282A4 Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides |
| 04/07/2004 | EP1303267B1 Dermal for amino laevulinic acid |
| 04/07/2004 | EP1292299B1 New use of citreamicins |
| 04/07/2004 | EP1218404A4 A binding motif of a receptor |
| 04/07/2004 | EP1147773B1 Medicinal compositions for treating osseous lesion in multiple myeloma |
| 04/07/2004 | EP1086077B1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application |
| 04/07/2004 | EP1001756B1 Synergistically acting compositions for selectively combating tumor tissue |
| 04/07/2004 | EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 04/07/2004 | EP0918776B1 Total synthesis of antitumor acylfulvenes |
| 04/07/2004 | EP0889905B1 Cytokine antagonists and agonists |
| 04/07/2004 | EP0787148B1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 04/07/2004 | EP0712312B1 Suppression of inhibitors |
| 04/07/2004 | EP0549742B1 USE OF CANPs-INHIBITORS IN PHARMACEUTICAL PREPARATIONS |
| 04/07/2004 | CN1487942A Hexahydropyrrolo [1,2-c] pyrimidines as antiviral, antifungal and/or antitumor agents |
| 04/07/2004 | CN1487941A Synthesis of temozolomide and analogs |
| 04/07/2004 | CN1487939A Amido ether substituted imidazoquinolines |
| 04/07/2004 | CN1487936A Medicinal compositions having improved absorbability |
| 04/07/2004 | CN1487935A Medicinal compositions improved in solubility in water |
| 04/07/2004 | CN1487934A 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1487931A Naphthostyrils compounds |
| 04/07/2004 | CN1487927A Diaminothiazoles |
| 04/07/2004 | CN1487925A Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors |
| 04/07/2004 | CN1487924A Farnesyl transferase inhibitors |
| 04/07/2004 | CN1487840A Molecular antigen array |
| 04/07/2004 | CN1487838A Molecular antigen array |
| 04/07/2004 | CN1487798A Combination of probiotics |
| 04/07/2004 | CN1487089A Prepn process of sulfogalacto oligose with antitumor activity |
| 04/07/2004 | CN1487081A Cloning and expression of Baimei pit viper Aidingbit CDNA for treating tumor |
| 04/07/2004 | CN1486985A Synthesis of anticancer medicine Raltiprexed |
| 04/07/2004 | CN1486740A Chinese medicine composition for treating cancer |
| 04/07/2004 | CN1486736A Fibrillation-resisting liver softening bolus as compound Chinese medicine prepn for treating fibrillation and cirthosis of liver |
| 04/07/2004 | CN1486734A Tumor eliminating capsule |
| 04/07/2004 | CN1486712A Extractive of Chinese medicinal material rabdosia as antitumor medicine and its prepn process |
| 04/07/2004 | CN1486694A Cancer treating medicine |
| 04/07/2004 | CN1486692A Plant extractive for treating cancer |
| 04/07/2004 | CN1486691A Bolengsu compound and its prepn, medicine composition and use |
| 04/07/2004 | CN1144834C Process for modifying polylacticacid by adopting unsaturated cyclic anhydride or unsaturated cyclic imide, modified product and application |
| 04/07/2004 | CN1144816C Novel antproliferative protein from bacillus thuringiensis var. Thuringiensis |
| 04/07/2004 | CN1144799C N-(iminomethyl) amine derivatives, their preparation, their use as medicines and medical compositions containing the same |
| 04/07/2004 | CN1144786C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/07/2004 | CN1144785C Hydroxamic acid and its preparation, and pharmaceutical composition |
| 04/07/2004 | CN1144595C Anticancer capsule and preparing mehtod thereof |
| 04/07/2004 | CN1144594C External-use plaster for softening dry feces and dissipating mass |
| 04/07/2004 | CN1144592C Use of camptotheicin derivatives with reduced gastrointestinal toxicity |
| 04/07/2004 | CN1144591C Application of Sichuan champion bauhinia saponin in preparing anti-tumor medicine |
| 04/07/2004 | CN1144587C Agents for relieving side effects |
| 04/07/2004 | CN1144586C 2-(1-hydroxyethyl)-5-hydroxynaphtho[2,3-B] furan-4,9-dione and antitumor agents comprising this compound |
| 04/06/2004 | US6717017 4'-alkyl,6'-(protected hydroxy),7'-hydroxy-spiro(cyclopropane-1,5'-hexahydroindan-2,3 a(4),7a(1)-triene) compound of given formula, intermediate to illudin analogs of the mushroom omphalotus illudens |
| 04/06/2004 | US6716978 For therapy and prohylaxis of inflammatory diseases including joint inflammation, crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (copd) including asthma, chronic bronchitis |
| 04/06/2004 | US6716968 Apoptosis-related antigenic compounds of specified amino acid sequence; inhibition of cell apoptosis; antibodies for stimulation of cell apoptosis; immunoassay to determine rate of apoptosis in tissues |
| 04/06/2004 | US6716880 Function as sulfatase and/or blocking estrogen receptors; prophylaxis and therapy |
| 04/06/2004 | US6716879 Administering an effective amount of sulfonylamino-substituted n-aryl- or heteroacryl or alkyl or cycloalkylcarboxamide derivatives or salts, esters, amides or prodrug to treat tumor |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716870 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 04/06/2004 | US6716865 Benzoxa- and benzthiazoles |
| 04/06/2004 | US6716863 Heterocyclic compounds their production and use |
| 04/06/2004 | US6716856 Cell proliferative disorders or alzheimer's disease; reduced toxicity; cdk/cyclin kinase inhibitory activity |
| 04/06/2004 | US6716849 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 04/06/2004 | US6716847 Antiallergens, antiinflammatory |
| 04/06/2004 | US6716845 Barbituric acid derivatives |
| 04/06/2004 | US6716843 Inhibitor of dipeptidyl-peptidase iv |